Clinical Trial Update: Dose Ranging Study of Combined Haemophilus Influenzae Type B-Meningococcal Serogroups CY (Hib-MenCY-TT) Vaccine [Phase 2]

View source ↗

Summary

Phase 2 dose-ranging study evaluating Hib-MenCY-TT vaccine; completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilus Influenzae Type Disease
• Meningococcal Disease

Drugs mentioned

• Hib-MenCY-TT

Snippet

Sponsor: GlaxoSmithKline | Conditions: Haemophilus Influenzae Type b, Neisseria Meningitidis | Phase 2 | Status: COMPLETED | Results posted: 2012-07-23